Lundbeck

Talking about #mentalhealth in Mexico 🧠📢 In Mexico, 25% of the population lives with mental health conditions. However, only 2% of the national health budget is allocated to mental health, highlighting the need for greater awareness. In 2023, Lundbeck Mexico launched ‘Hablamos (Let’s Talk)’, a special project that collaborates with patient associations specializing in supporting people living with mental health conditions in their rehabilitation and recovery processes. To increase awareness of what it is like to live with a psychiatric disorder, Hablamos collected testimonials from people living in cities like Mexico City, Monterrey, and Guadalajara, sharing their touching stories with us. At Lundbeck, we recognize the importance of sharing the stories of people with lived experiences to eradicate stigma and show the person behind the diagnosis. We believe it is vital to provide support to people who cannot access comprehensive care to recover their ordinary lives. By fostering partnerships, we can help restore #brainhealth and improve the lives of people living with psychiatric and neurological disorders in Mexico and around the world. 🌍 Curious to learn more about how we spread awareness in the countries where we operate? Read about our actions in our most recent Sustainability Report: https://lnkd.in/gizqug9 #Awareness #UnitedAgainstStigma

This June, our Lundbeck colleagues in the US and Canada have celebrated another Migraine and Headache Awareness Month, an annual campaign to raise awareness, reduce stigma, and build a stronger community of advocates. This year, our initiatives in the US kicked off early with a cross-business presence at the New York Yankees Brain Health Awareness Game. Our US and global leaders also joined the Shades for Migraine movement, donning sunglasses to show our support. Additionally, our Lundbeck US colleagues made a strong appearance at the Chicago Miles for Migraine Walk/Run. In Canada, we supported initiatives to improve the quality of life for those living with migraine and other headache conditions. We continued our long-standing partnerships with patient organizations through wellness programs, webinars, workshops, and advocacy activities and awareness campaigns such as Move for Migraine. Additionally, we supported efforts to provide expert guidance and education to healthcare professionals. In recognition of World Migraine Awareness Day, landmarks across Canada were illuminated in purple. Together, we are making strides in addressing migraine and headache disorders. Let’s continue to support and advocate for those affected 💜 #Migraine #Awareness

Did you know that chronic migraine means that people are affected by headache at least 15 days per month for at least three months?* Migraine can significantly impact a person’s quality of life, but taking proactive steps may help prevent episodic migraine from becoming chronic. Discover how small changes in a daily routine, managing triggers, and seeking the right medical support can make a big impact 👇 Help spread awareness of chronic migraine and share this infographic with your network! #Migraine #Awareness #NotJustAHeadache *Source: Headache Classification Committee of the International Headache Society (IHS)

Celebrating a decade of excellence: GBS Krakow’s 10th anniversary 🎉 Ten years ago, Group Business Service (GBS) Krakow embarked on a journey to become Lundbeck’s agile force, adapting swiftly to the ever-changing market. From a team of 100, they’ve grown into a global hub, managing 30 service lines with expertise and dedication. Last week, the team gathered at the historic Aviation Museum in Krakow to celebrate this milestone. GBS Krakow also takes great pride in its CSR initiatives that contribute to enhancing overall well-being and quality of life. This passion translates into projects that extend their impact beyond the workplace. Last year, over 80 employees participated in 6 employee-driven, bottom-up CSR projects. Additionally, they joined 11 annual charitable business runs and organized numerous collections to support children, families, and individuals. “From our beginnings as a relatively unknown company, GBS Krakow has transformed into a vibrant community of specialists which has been recognized and certified as a great place to work for several years,” states Marcin Mlynarczyk, Vice President & Managing Director of GBS Krakow, acknowledging the center’s influence beyond mere business metrics. In recognition of GBS’s dedication, exceptional service delivery, and progression from a support function to a center of expertise, Joerg Hornstein, CFO & Head of Corporate Functions, remarks: “A lot of strategically important and cross-functional projects are delivered from Krakow and we have strong foundations of standardized and optimized processes to be now taken to the next level through automation and digitally-enabled transformation.” Here’s to the next decade of innovation and excellence at GBS Krakow! #Teamwork #Innovation

As focused innovators, we recognize that innovation lives with all of us. In the US, we launched our very own ThinkLab and recently held an idea incubation workshop with our partner, MATTER Chicago. We know there’s no limit to the potential we can unlock by empowering our teams’ creativity and innovative thinking. Together we are improving the known and creating the new.

Saluting our stars: Sales Representatives of the Year 2023 ⭐   Our sales representatives tirelessly engage with customers every day, ensuring that patients have access to our innovative treatments. They are the driving force behind our strategic brands, helping us perform while transforming to become a #FocusedInnovator.   This year, we proudly celebrate the 22nd Sales Representatives of the Year (SROY) event, welcoming 49 outstanding sales reps from 37 different markets to our headquarters in Valby, Denmark. From our dedicated team of 2500 sales reps, the top 2% have been awarded this prestigious recognition.   Let’s join together in celebrating their achievements and look forward to many more years of success and innovation.   Check out what our Commercial Heads have to say about this important event in the graphic below 👇 #Sales #Excellence

Lundbeck advocates for public-private partnerships in Italy From June 18-20, 2024, Lundbeck joined forces with DI - Dansk Industri, Healthcare Denmark, and the Embassy of Denmark in Italy to inspire a new wave of public-private partnerships (PPP) in the healthcare sector. During our visit to Rome, we showcased the Danish Lighthouse Life Science public-private partnership, a pioneering initiative we’re proudly heading with other industry leaders – currently with a focus on #mentalhealth. Our presentation and panel discussion highlighted the transformative potential of PPPs, using the Lighthouse Life Science (Erhvervsfyrtårn Life Science) as a prime example. We aimed to inspire Italian institutions and key national health service opinion leaders to consider PPPs as a strategic approach to bolster their healthcare system. The delegation visit was a unique opportunity to present Denmark’s strongholds and innovative solutions in pharmaceuticals and medical devices. By sharing our experiences and successes in this area, we hope to pave the way for a sustainable and innovative healthcare service of tomorrow. Together, let’s build a future where we collaborate seamlessly across sectors to enhance healthcare for all! #PublicPrivatePartnership #LifeScience #Healthcare #Innovation

This morning, Lundbeck hosted a significant event as four key ministers from the Danish government visited our headquarters to unveil a new policy plan aimed at supporting Danish industry and business. This plan included an increase in the R&D tax deduction from 108% to 120%, reflecting our persistent advocacy efforts. We consider this initiative an important step towards future-proofing Danish Life Science. The ministers present were Troels Lund Poulsen, Deputy Prime Minister and Minister of Defence; Lars Løkke Rasmussen, Minister of Foreign Affairs; Morten Bødskov, Minister of Business, Industry and Financial Affairs; and Jeppe Bruus, Minister of Taxation. Several Danish media outlets also attended to cover the event. The government’s choice to launch their plan at Lundbeck highlights our status as a leading Danish R&D-based company with a substantial impact. Our active role in discussions about enhancing tax incentives for R&D-based companies was recognized, and this visit underscores our strong engagement with policymakers. #Innovation #DanishLifeScience #PolicyUpdate

Lundbeck advances neurohormonal research with new Cushing’s Disease study 🔬 Lundbeck is taking a significant step in neurohormonal dysfunctions by launching a phase II study of Lu AG13909, a monoclonal antibody targeting ACTH. This potential treatment aims to reduce elevated ACTH levels, offering potential relief for those with Cushing’s disease. “We are pleased to advance this new approach to potentially treating unmet needs in Cushing’s disease, a condition that, when uncontrolled, is debilitating and increases mortality,” said Johan Luthman, EVP and Head of Research & Development at Lundbeck. This study underscores Lundbeck’s commitment to innovation and expanding treatment options for people with rare neurohormonal dysfunctions. Click here to read the press release: https://lnkd.in/eYRgtmmx #FocusedInnovator 

Celebrating 25 years as a public company Today marks 25 years since Lundbeck’s landmark stock market listing on the Copenhagen Stock Exchange. This strategic step has been instrumental in fueling our journey of developing treatments that make a difference to people affected by psychiatric and neurological disorders. As we celebrate a quarter-century of Lundbeck being a listed company, we express our gratitude to our shareholders, partners, and our Lundbeck colleagues for their unwavering support! #FocusedInnovator #anniversary